This study reveals that ITPRIPL1 plays a dual role in glioma: It suppresses T cell–mediated immune responses, contributing to an immunosuppressive microenvironment, and interferes with the efficacy of antitumor drugs, thereby promoting tumor progression and ultimately leading to poor patient prognosis. The gene discussed is ITPRIPL1; the disease is neoplasm.